Literature DB >> 31088817

Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.

Eric E Jung1, F Scott Heinemann2, Colt A Egelston3, Jennifer Wang1, Raphael E Pollock4, Peter P Lee3, William W Tseng1.   

Abstract

A 62-year-old man presented with concurrent sigmoid colon adenocarcinoma and small bowel mesenteric dedifferentiated liposarcoma. Following surgical resection of the colon cancer, complete excision of the mesenteric sarcoma and adjuvant folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy, the patient demonstrated no radiological evidence of disease for more than 2 years. The patient then developed synchronous recurrence of both cancers: the colon cancer metastasised to the liver and a pelvic lymph node, and the liposarcoma recurred in the original location. The patient underwent additional chemotherapy with complete response of the metastatic colon cancer and stable disease for the liposarcoma. The recurrent mesenteric tumour was subsequently resected. Although concurrent cancers have been reported, this unique case of synchronous recurrence raises interesting hypotheses regarding host-tumour interaction and immune surveillance. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  immunology; surgical oncology

Mesh:

Year:  2019        PMID: 31088817      PMCID: PMC6536183          DOI: 10.1136/bcr-2018-228868

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Monogenic and polygenic determinants of sarcoma risk: an international genetic study.

Authors:  Mandy L Ballinger; David L Goode; Isabelle Ray-Coquard; Paul A James; Gillian Mitchell; Eveline Niedermayr; Ajay Puri; Joshua D Schiffman; Gillian S Dite; Arcadi Cipponi; Robert G Maki; Andrew S Brohl; Ola Myklebost; Eva W Stratford; Susanne Lorenz; Sung-Min Ahn; Jin-Hee Ahn; Jeong Eun Kim; Sue Shanley; Victoria Beshay; Robert Lor Randall; Ian Judson; Beatrice Seddon; Ian G Campbell; Mary-Anne Young; Rajiv Sarin; Jean-Yves Blay; Seán I O'Donoghue; David M Thomas
Journal:  Lancet Oncol       Date:  2016-08-04       Impact factor: 41.316

Review 2.  Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Authors:  Aaron W James; Le Chang; Scott Genshaft; Sarah M Dry
Journal:  J Orthop       Date:  2014-11-26

3.  Recurrent retroperitoneal liposarcoma in a patient with neurofibromatosis type I.

Authors:  Carrie K Gomez; Gerald Rosen; Robin Mitnick; Ali Chaudhri
Journal:  BMJ Case Rep       Date:  2012-06-05

4.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16

5.  Liposarcoma of the forearm in a man with type 1 neurofibromatosis: a case report.

Authors:  Markus Dietmar Schofer; Mohammed Yousef Abu-Safieh; Jürgen Paletta; Susanne Fuchs-Winkelmann; Bilal Farouk El-Zayat
Journal:  J Med Case Rep       Date:  2009-04-29

Review 6.  Cancer immunotherapy targeting neoantigens.

Authors:  Yong-Chen Lu; Paul F Robbins
Journal:  Semin Immunol       Date:  2015-11-30       Impact factor: 11.130

Review 7.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

Review 8.  Cytokine patterns in patients with cancer: a systematic review.

Authors:  Bodo E Lippitz
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

Review 9.  T Cell Dysfunction in Cancer.

Authors:  Daniela S Thommen; Ton N Schumacher
Journal:  Cancer Cell       Date:  2018-04-09       Impact factor: 31.743

Review 10.  Tumor macroenvironment and metabolism.

Authors:  Wael Al-Zoughbi; Wael Al-Zhoughbi; Jianfeng Huang; Ganapathy S Paramasivan; Holger Till; Martin Pichler; Barbara Guertl-Lackner; Gerald Hoefler
Journal:  Semin Oncol       Date:  2014-03-01       Impact factor: 4.929

View more
  2 in total

1.  Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.

Authors:  FeiYan Ai; Wenhao Wang; Shaojun Liu; Decai Zhang; Zhenyu Yang; Fen Liu
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  Synchronous Occurrence of Advanced Gastric Carcinoma with Retroperitoneal Liposarcoma: A Case Report.

Authors:  Hiroshi Kobayashi; Riuko Ohashi; Masuo Ujita; Kana Ueki; Ryouya Seki; Shintaro Fukuda; Brian Rubin
Journal:  Am J Case Rep       Date:  2022-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.